TY - CHAP
T1 - Validation procedure for multiplex antibiotic immunoassays using flow-based chemiluminescence microarrays
AU - Meyer, Verena Katharina
AU - Meloni, Daniela
AU - Olivo, Fabio
AU - Märtlbauer, Erwin
AU - Dietrich, Richard
AU - Niessner, Reinhard
AU - Seidel, Michael
N1 - Publisher Copyright:
© Springer Science+Business Media New York 2017.
PY - 2017
Y1 - 2017
N2 - Small molecules like antibiotics or other pharmaceuticals can be detected and quantified,among others,with indirect competitive immunoassays. With regard to multiplex quantification,these tests can be performed as chemiluminescence microarray immunoassays,in which,in principle,the analyte in the sample and the same substance immobilized on the chip surface compete for a limited number of specific antibody binding sites. The amount of the specific primary antibody that has been bound to the surface is visualized by means of a chemiluminescence reaction. Validated quantitative confirmatory methods for the detection of contaminants,for example drug residues,in food samples usually comprise chromatographic analysis and spectrometric detection,e.g.,HPLC-MS,GC-MS,or GC with electron capture detection. Here,we describe a validation procedure (according to the Commission Decision of the European Communities 2002/657/EC) for multiplex immunoassays performed as flow-through chemiluminescence microarrays,using the example of a small molecule microarray for the simultaneous detection of 13 antibiotics in milk. By this means,we suggest to accept multianalyte immunoassays as confirmatory methods as well,to benefit from the advantages of a fast automated method that does not need any pretreatment of the sample. The presented microarray chip is regenerable,so an internal calibration is implemented. Therefore,the analytical results are highly precise,combined with low costs (the aim for commercialization is less than 1 € per analyte per sample,this is significantly less than HPLC-MS).
AB - Small molecules like antibiotics or other pharmaceuticals can be detected and quantified,among others,with indirect competitive immunoassays. With regard to multiplex quantification,these tests can be performed as chemiluminescence microarray immunoassays,in which,in principle,the analyte in the sample and the same substance immobilized on the chip surface compete for a limited number of specific antibody binding sites. The amount of the specific primary antibody that has been bound to the surface is visualized by means of a chemiluminescence reaction. Validated quantitative confirmatory methods for the detection of contaminants,for example drug residues,in food samples usually comprise chromatographic analysis and spectrometric detection,e.g.,HPLC-MS,GC-MS,or GC with electron capture detection. Here,we describe a validation procedure (according to the Commission Decision of the European Communities 2002/657/EC) for multiplex immunoassays performed as flow-through chemiluminescence microarrays,using the example of a small molecule microarray for the simultaneous detection of 13 antibiotics in milk. By this means,we suggest to accept multianalyte immunoassays as confirmatory methods as well,to benefit from the advantages of a fast automated method that does not need any pretreatment of the sample. The presented microarray chip is regenerable,so an internal calibration is implemented. Therefore,the analytical results are highly precise,combined with low costs (the aim for commercialization is less than 1 € per analyte per sample,this is significantly less than HPLC-MS).
KW - Antibiotics
KW - Chemiluminescence
KW - Competitive immunoassay
KW - Flow-based analysis platform
KW - Microarrays
KW - Regeneration
KW - Residue analysis
KW - Screening methods
KW - Veterinary drugs
UR - https://www.scopus.com/pages/publications/84996549903
U2 - 10.1007/978-1-4939-6584-7_13
DO - 10.1007/978-1-4939-6584-7_13
M3 - Chapter
C2 - 27873208
AN - SCOPUS:84996549903
T3 - Methods in Molecular Biology
SP - 195
EP - 212
BT - Methods in Molecular Biology
PB - Humana Press Inc.
ER -